France-based NovAliX has entered into a fragment-based drug discovery project with Japanese biopharmaceutical firm Kyowa Hakko Kirin. The deal, which is a continuation of the alliance announced in January 2013, builds upon the positive ...
Inventiva and Novalix have entered into a strategic alliance to discover the clinical candidates, targeting nuclear receptors. As part of the agreement, Inventiva and NovAliX offer pharmaceutical and biotech companies a set of fully ...
Tags: NovAliX, clinical candidates